Fluvoxamine rescues mitochondrial Ca2 + transport and ATP production through σ1-receptor in hypertrophic cardiomyocytes

Life Sciences

Volumn 95, Issue 2, 2014, Pages 89-100

  Tagashira, Hideaki ^a   Bhuiyan, Md Shenuarin ^b   Shioda, Norifumi ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

1 receptor; ATP; Fluvoxamine; Mitochondrial Ca2 + transport; Myocardial hypertrophy

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; CALCIUM; FLUVOXAMINE MALEATE; IP3 RECEPTOR; PHENYLEPHRINE; RECEPTOR; RYANODINE RECEPTOR; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL STIMULATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG POTENTIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; RAT; SARCOPLASMIC RETICULUM;

MUS; RATTUS;

ATP; FLUVOXAMINE; MITOCHONDRIAL CA(2+) TRANSPORT; MYOCARDIAL HYPERTROPHY; Σ(1) RECEPTOR;

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ANIMALS; CALCIUM; CARDIOMEGALY; CELLS, CULTURED; FLUVOXAMINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MITOCHONDRIA; MYOCYTES, CARDIAC; RATS; RECEPTORS, SIGMA; SEROTONIN UPTAKE INHIBITORS;

EID: 84892820556     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.019     Document Type: Article

References (42)

1. 2 + leak in heart failure Circ Res 97 2005 1314 1322
2. M.S. Amer, L. McKeown, S. Tumova, R. Liu, V.A. Seymour, and L.A. Wilson et al. Inhibition of endothelial cell Ca(2 +) entry and transient receptor potential channels by Sigma-1 receptor ligands Br J Pharmacol 168 6 2013 1445 1455
3. C.W. Balke, and S.R. Shorofsky Alterations in calcium handling in cardiac hypertrophy and heart failure Cardiovasc Res 37 2 1998 290 299
4. D.J. Bare, C.S. Kettlun, M. Liang, D.M. Bers, and G.A. Mignery Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II J Biol Chem 280 2005 15912 15920
5. 2 +]i during caffeine contractures in rabbit cardiac myocytes J Physiol 453 1992 591 608
6. C.J. Bell, N.A. Bright, G.A. Rutter, and E.J. Griffiths ATP regulation in adult rat cardiomyocytes: time-resolved decoding of rapid mitochondrial calcium spiking imaged with targeted photoproteins J Biol Chem 281 38 2006 28058 28067
7. M.S. Bhuiyan, and K. Fukunaga Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats Expert Opin Ther Targets 13 2009 1253 1265
8. M.S. Bhuiyan, N. Shioda, M. Shibuya, Y. Iwabuchi, and K. Fukunaga Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats Hypertension 53 2009 57 63
9. M.S. Bhuiyan, H. Tagashira, and K. Fukunaga Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions Expert Opin Ther Targets 14 10 2010 1009 1022
10. M.S. Bhuiyan, H. Tagashira, and K. Fukunaga Dehydroepiandrosterone mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding Cardiovasc Ther 29 4 2010 219 230
11. M.S. Bhuiyan, H. Tagashira, and K. Fukunaga Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding Eur J Pharmacol 650 2-3 2011 621 628
12. R.M. Denton, P.J. Randle, and B.R. Martin Stimulation by calcium ions of pyruvate dehydrogenase phosphate phosphatase Biochem J 128 1972 161 163
13. P. Eder, and J.D. Molkentin TRPC channels as effectors of cardiac hypertrophy Circ Res 108 2 2011 265 272
14. S. Givvimani, C. Munjal, N. Tyagi, U. Sen, N. Metreveli, and S.C. Tyagi Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure PLoS One 7 2012 e32388
15. L.O. Go, M.C. Moschella, J. Watras, K.K. Handa, B.S. Fyfe, and A.R. Marks Differential regulation of two types of intracellular calcium release channels during end-stage heart failure J Clin Invest 95 1995 888 894
16. 2 + transients and arrhythmias associated with cardiac hypertrophy Proc Natl Acad Sci U S A 106 2009 11406 11411
17. K. Hashimoto Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression Prog Neurobiol 100 2013 15 29
18. 2 + signaling and cell survival Cell 131 2007 596 610
19. 2 + release from the sarcoplasmic reticulum as subcellular mechanism of cardiac contractile dysfunction J Mol Cell Cardiol 50 3 2011 390 400
20. 2 + release is a nexus for hypertrophic signaling in cardiac myocytes Mol Cell 33 2009 472 482
21. K. Ito, Y. Hirooka, R. Matsukawa, M. Nakano, and K. Sunagawa Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression Cardiovasc Res 93 2012 33 40
22. P.J. Kannankeril, B.M. Mitchell, S.A. Goonasekera, M.G. Chelu, W. Zhang, and S. Sood et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy Proc Natl Acad Sci U S A 103 32 2006 12179 12184
23. 2 + signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate (IP3)-receptor type 2-deficient mice Circ Res 96 2005 1274 1281
24. Y.M. Lu, N. Shioda, F. Han, S. Moriguchi, J. Kasahara, and Y. Shirasaki et al. Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes Biochem Pharmacol 74 12 2007 1727 1737
25. J.G. McCormack, and R.M. Denton The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase complex Biochem J 180 1972 533 544
26. M.C. Mohl, S.E. Iismaa, X.H. Xiao, O. Friedrich, S. Wagner, and V. Nikolova-Krstevski et al. Regulation of murine cardiac contractility by activation of α(1A)-adrenergic receptor-operated Ca(2 +) entry Cardiovasc Res 91 2 2011 310 319
27. 2 + Proc Natl Acad Sci U S A 98 6 2001 3197 3202
28. H. Nakayama, I. Bodi, M. Maillet, J. DeSantiago, T.L. Domeier, and K. Mikoshiba et al. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli Circ Res 107 5 2010 659 666
29. T. Niizeki, Y. Takeishi, T. Kitahara, T. Arimoto, M. Ishino, and O. Bilim et al. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade Am J Physiol Heart Circ Physiol 295 1 2008 H245 H255
30. M. Novakova, V. Bruderova, Z. Sulova, J. Kopacek, L. Lacinova, and R. Kvetnansky et al. Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions Gen Physiol Biophys 26 2007 110 117
31. S.B. Ong, S. Subrayan, S.Y. Lim, D.M. Yellon, S.M. Davidson, and D.J. Hausenloy Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury Circulation 121 18 2010 2012 2022
32. N. Onohara, M. Nishida, R. Inoue, H. Kobayashi, H. Sumimoto, and Y. Sato et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy EMBO J 25 22 2006 5305 5316
33. W. Pendergrass, N. Wolf, and M. Poot Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues Cytometry A 61 2 2004 162 169
34. N. Shioda, K. Ishikawa, H. Tagashira, T. Ishizuka, H. Yawo, and K. Fukunaga Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma-1 receptor, promotes mitochondrial energy depletion and apoptosis J Biol Chem 287 28 2012 23318 23331
35. T.P. Su, T. Hayashi, T. Maurice, S. Buch, and A.E. Ruoho The sigma-1 receptor chaperone as an inter-organelle signaling modulator Trends Pharmacol Sci 31 2010 557 566
36. H. Tagashira, Shioda N. BhuiyanMS, H. Hasegawa, H. Kanai, and K. Fukunaga Sigma-1 receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice Am J Physiol Heart Circ Physiol 299 5 2010 H1535 H1545
37. H. Tagashira, Shioda N. BhuiyanMS, and K. Fukunaga Distinct cardioprotective effects of 17ï¢-estradiol and dehydroepiandrosterone on pressure-overload-induced hypertrophy in ovariectomized female rats Menopause 18 12 2011 1317 1326
38. H. Tagashira, C. Zhang, Y.M. Lu, H. Hasegawa, H. Kanai, and F. Han et al. Stimulation of σ(1)-receptor restores abnormal mitochondrial Ca(2 +) mobilization and ATP production following cardiac hypertrophy Biochim Biophys Acta 1830 4 2013 3082 3094
39. C.B. Taylor, M.E. Youngblood, D. Catellier, R.C. Veith, R.M. Carney, and M.M. Burg et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction Arch Gen Psychiatry 62 2005 792 798
40. R.J. van Oort, J.L. Respress, N. Li, C. Reynolds, A.C. De Almeida, and D.G. Skapura et al. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model Hypertension 55 4 2010 932 938
41. R. Ventura-Clapier, A. Garnier, V. Veksler, and F. Joubert Bioenergetics of the failing heart Biochim Biophys Acta 1813 2011 1360 1372
42. Y. Zou, Y. Liang, H. Gong, N. Zhou, H. Ma, and A. Guan et al. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy Hypertension 58 6 2011 1099 1110